"instanceType","description","uuid:ID","label","id","name","text"
"OBJECTIVE","Main objective","5e26081d-9785-4437-8bb3-9c05bcf15ec4","","Objective_1","OBJ1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"OBJECTIVE","Safety","b9b5b243-1afe-41e5-8297-686180d43f6c","","Objective_2","OBJ2","To document the safety profile of the xanomeline TTS."
"OBJECTIVE","Behaviour","50ce92c0-5c18-4835-a2fa-deb3412b9b8a","","Objective_3","OBJ3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
